🎉 Exciting News! 🎉. SafeHeal® recently closed an oversubscribed €35 million Series C equity financing, led by Solar Eclipse with new investors Gideon Strategic Partners and M&L Healthcare (part of M&L Group), and continued support from Sofinnova Partners and a leading.

We’re proud to announce the successful completion of enrollment in our Standard of Care (SH-SOC23) arm, the first phase of our two-part study in rectal cancer surgery! 🚀. 🔜 Next Up: Once IDE approval is obtained, SafeHeal will initiate the SAFE-3CV study, which will evaluate

Currently enrolling at several sites throughout the US/ EU. Visit to learn more about our study, sites and what we are doing to lessen the burden of #rectalcancer patients requiring a temporary ostomy.

Busy Month at Lankenau Hospital w/ Dr. John Marks! Dr. Marks enrolled 3 patients this month in the @safeheal SOC23 study which will provide robust Standard-of-Care Control data to which a future stoma alternative can be compared.

Welcome @davidjhiller and his team @NovantHealth to the SafeHeal SOC trial. If you or someone you know must undergo #rectalcancer surgery w/diverting ostomy please reach out him to see if you are eligible for our clinical trial. Visit for information.

Honored to be working with @JohnMarksMD and @schoonyoung @mainlinehealth (Lankenau Hospital) as we seek an alternative to temporary diverting stoma. #RectalCancer . Visit to learn more/participate in our study.

A Big Welcome to the latest site to be activated for our SafeHeal SOC23 Study: Lankenau Hospital .

Congratulations @WCMSurgery/@NYPhospital for your first enrolled patient in the SafeHeal SOC23 trial! We are so excited and honored to be aligned with you. @D_JafariMD #colorectalanastomosisprotection.

RT @MedTechAwards: We're excited to announce our 2016 Finalists: @dynamicbrace @cataliahealth @safeheal & @mitcheggers1 Congratulations! Se….

RT @lifesciencevc: Congratulations to the @MedTechAwards 2016 finalists @dynamicbrace @safeheal @cataliahealth and Adient Medical! Can't wa….

SafeHeal is a proud finalist of the MedTech Innovator at AdvaMed 2016 ! @advamedconf @medtechawards @safeheal

#safeheal Avoid the delibitation of ostomies and the need for the ostomy takedown surgery - a huge win for patients ! #medtechinnovator.

Proud and honored to be part of that program ! #medtechinnovator

A8 : not really if you're providing a disruptive approach / product. but people might shy away due to the risk profile #MedTechInnovator.

A6 : EU notified bodies are extremely late in delivering their reports due to excessive workload after the CE mark changes #MedTechInnovator.

A4 : Derisk your regulatory pathway early in your development, with CE clinical pathway review with NB and FDA pre-sub #MedTechInnovator.

@tueohealth . and medtech investors do not understand digital health either ;-) #MedTechInnovator.

The milestone needed to raise Series A capital seems to have shifted to proof-of-concept to first-in-man for many VCs. #MedTechInnovator.

The milestone needed to achieve to raise Series A capital seems to have shifted to proof-of-concept to first-in-man for many VCs. tricky !.

Hi, I'm Anne Osdoit, founder and CEO of SafeHeal @safeheal . Happy to join this chat ! #MedTechInnovator.